Regulation of vascular endothelial growth factor receptor-2 (Flk-1) expression in vascular endothelial cells

Experimental Cell Research

Volumn 241, Issue 2, 1998, Pages 414-425

  Pepper, Michael S ^a   Mandriota, Stefano J ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Blood vessel; Cell growth; Endothelial cell; Extracellular matrix; Growth factor; Plasminogen activator

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; PLASMINOGEN ACTIVATOR; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BASEMENT MEMBRANE; BLOOD VESSEL PERMEABILITY; CELL GROWTH; CELL TRANSFORMATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HYPOXIA; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM;

ANIMALIA; BOVINAE;

EID: 0032527008     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4072     Document Type: Article

References (67)

1. Dvorak H. F., Brown L. F., Detmar M., Dvorak A. M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146:1995;1029-1039.
2. Pepper M. S., Mandriota S. J., Vassalli J.-D., Orci L., Montesano R. Angiogenesis regulating cytokines: activities and interactions. Curr. Top. Microbiol. Immunol. 213:1996;31-67.
3. Christofori G. The Role of Fibroblast Growth Factors in Tumour Progression and Angiogenesis in Tumour Angiogenesis. 1997;Oxford Univ. Press, London. p. 201-237.
4. Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocrine Rev. 18:1997;4-25.
5. Maglione D., Guerriero V., Viglietto G., Delli-Bovi P., Persico M. G. Isolation of a human placenta cDNA coding for a protein related to vascular permeability factor. Proc. Natl. Acad. Sci. USA. 88:1991;9267-9271.
6. Grimmond S., Lagercrantz J., Drinkwater C., Silins G., Townson S., Pollock P., Gotley D., Carson E., Rakar S., Nordenskjöld M., Ward L., Hayward N., Weber G. Cloning and characterization of a novel human gene related to vascular endothelial growth factor. Genome Res. 6:1996;124-131.
7. Olofsson B., Pajusola K., Kaipainen A., von Euler G., Joukov V., Saksela O., Orpana A., Pettersson R. F., Alitalo K., Eriksson U. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc. Natl. Acad. Sci. USA. 93:1996;2576-2581.
8. Townson S., Lagercrantz J., Grimmond S., Silins G., Nordenskjöld M., Weber G., Hayward N. Characterization of the murine VEGF-related factor gene. Biochem. Biophys. Res. Commun. 220:1996;922-928.
9. Joukov V., Pajusola K., Kaipainen A., Chilov D., Lahtinen I., Kukk E., Saksela O., Kalkkinen N., Alitalo K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15:1996;290-298.
10. Lee J., Gray A., Yuan J., Luoh S. M., Avraham H., Wood W. I. Vascular endothelial growth factor-related protein: A ligand and specific activator of the tyrosine kinase receptor FLT4. Proc. Natl. Acad. Sci. USA. 93:1996;1988-1992.
11. Orlandini M., Marconcini L., Ferruzzi R., Oliviero S. Identification of a c-fos. Proc. Natl. Acad. Sci. USA. 93:1996;11675-11680.
12. Achen M. G., Jeltsch M., Kukk E., Makinen T., Vitali A., Wilks A. F., Alitalo K., Stacker S. A. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk-1) and VEGF receptor 3 (Flt4). Proc. Natl. Acad. Sci. USA. 95:1998;548-553.
13. Shibuya M., Yamaguchi S., Yamane A., Ikeda T., Tojo A., Matsushime H., Sato M. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (fltfms. Oncogene. 5:1990;519-524.
14. Matthews W., Jordan C. T., Gavin M., Jenkins N. A., Copeland N. G., Lemischka I. R. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietc cells and exhibiting close genetic linkage to c-kit. Proc. Natl. Acad. Sci. USA. 88:1991;9026-9030.
15. Mustonen T., Alitalo K. Endothelial receptor tyrosine kinases involved in angiogenesis. J. Cell Biol. 129:1995;895-898.
16. Thomas K. A. Vascular endothelial growth factor, a potent and selective angiogenic agent. J. Biol. Chem. 271:1996;603-606.
17. Park J. E., Chen H. H., Winer J., Houck K. A., Ferrara N. Placenta growth factor: Potentiation of vascular endotelial growth factor bioactivityin vitroin vivo, J. Biol. Chem. 269:1994;25646-25654.
18. Olofsson, B. Korpeleinen, E. Kumar, V. Pepper, M. S. Mandriota, S. J. Aase, K. Gunji, Y. Shibuya, M. Alitalo, K. Eriksson, U. VEGF-B binds to VEGFR-1 and regulates plasminogen activator activity in endothelial cells.
19. Shalaby F., Rossant J., Yamaguchi T. P., Gertsenstein M., Wu X. F., Breitman M. L., Schuh A. C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature. 376:1995;62-66.
20. Fong G. H., Rossant J., Gertsenstein M., Breitman M. L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature. 376:1995;66-70.
21. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L., Collen D., Risau W., Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 380:1996;435-439.
22. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K. S., Powell-Braxton L., Hillan K. J., Moore M. W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 380:1996;439-442.
23. Pepper M. S., Ferrara N., Orci L., Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem. Biophys. Res. Commun. 189:1992;824-831.
24. Pepper M. S., Vassalli J.-D., Orci L., Montesano R. Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis. Exp. Cell Res. 204:1993;356-363.
25. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86:1996;353-364.
26. Risau W. Mechanisms of angiogenesis. Nature. 386:1997;671-674.
27. Mandriota S. J., Menoud P. A., Pepper M. S. Transforming growth factor-β1 downregulates vascular endothelial growth factor receptor-2/flk-1 expression in vascular endothelial cells. J. Biol. Chem. 271:1996;11500-11505.
28. Pepper M. S. Transforming growth factor-beta: vasculogenesis, angiogenesis and vessel wall integrity. Cytokine Growth Factor Rev. 8:1997;21-43.
29. Patterson C., Perrella M. A., Endege W. O., Yoshizumi M., Lee M.-E., Haber E. Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-a in cultured human vascular endothelial cells. J. Clin. Invest. 98:1996;490-496.
30. Mawatari M., Kohno K., Mizoguchi H., Matsuda T., Asoh K.-I., Van Damme J., Welgus H., Kuwano M. Effects of tumor necrosis factor and epidermal growth factor on cell morphology, cell surface receptors, and the production of tissue inhibitor of metalloproteinases and IL-6 in human microvascular endothelial cells. J. Immunol. 143:1989;1619-1627.
31. Nakatani S., Lu L., Okada N., Yoshikawa K. Phenotypic modulation of cultured endothelial cells in collagen matrices induced by tumor necrosis factor alpha. In vitro Cell. Dev. Biol. 30A:1994;192-197.
32. Sato N., Fukuda K., Nariuchi H., Sagara N. Tumor necrosis factor inhibiting angiogenesis in vitro. J. Natl. Cancer Inst. 79:1987;1383-1391.
33. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 359:1992;843-848.
34. Waltenberger J., Mayr U., Pentz S., Hombach V. Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. Circulation. 94:1996;1647-1654.
35. Brogi E., Schatteman G., Wu T., Kim E. A., Varticovski L., Keyt B., Isner J. M. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J. Clin. Invest. 97:1996;469-476.
36. Flamme I., Breier G., Risau W. Vascular endothelial growth factor (VEGF) and VEGF receptor 2 (flk-1) are expressed during vasculogenesis and vascular differentiation in the quail embryo. Dev. Biol. 169:1995;699-712.
37. Goto F., Goto K., Weindel K., Folkman J. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab. Invest. 69:1993;508-517.
38. Asahara T., Bauters C., Zheng L. P., Takeshita S., Bunting S., Ferrara N., Symes J. F., Isner J. M. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation. 92:1995;II365-II371.
39. Hu D. E., Fan T. P. D. Suppression of VEGF-induced angiogenesis by the protein tyrosine kinase inhibitor, lavendustin A. Br. J. Pharmacol. 114:1995;262-268.
40. Furie M. B., Cramer E. B., Naprstek B. L., Silverstein S. C. Cultured endothelial cell monolayers that restrict the transendothelial passage of macromolecules and electrical current. J. Cell Biol. 98:1984;1033-1041.
41. Pepper M. S., Montesano R., El Aoumari A., Gros D., Orci L., Meda P. Coupling and connexin 43 expression in microvascular and large vessel endothelial cells. Am. J. Physiol. 262:1992;C1246-C1257.
42. Montesano R., Orci L. Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell. 42:1985;469-477.
43. Rich B. E., Steitz J. A. Human acidic ribosomal phosphoproteins P0, P1, and P2: Analysis of cDNA clones, in vitro synthesis, and assembly. Mol. Cell. Biol. 7:1987;4065-4074.
44. Wool I. G., Chan Y. L., Gluck A., Suzuki K. The primary structure of rat ribosomal proteins P0, P1, and P2 and a proposal for a uniform nomenclature for mammalian and yeast ribosomal proteins. Biochimie. 73:1991;861-870.
45. Krowczynska A. M., Coutts M., Makrides S., Brawerman G. The mouse homologue of the human acidic ribosomal phosphoprotein P0: A highly conserved polypeptide that is under translational control. Nucleic Acids Res. 17:1989.
46. Chomczynski P., Sacchi N. Single-step method for RNA isolation by acid guanidinium thiocyanate-phenol-chlorophorm extraction. Anal. Biochem. 162:1987;156-159.
47. Isacchi A., Bergonzoni L., Sarmientos P. Complete sequence of a human receptor for acidic and basic fibroblast growth factors. Nucleic Acids Res. 18:1990.
48. Krätzschmar J., Haendler B., Kojima S., Rifkin D. B., Schleuning W. D. Bovine urokinase-type plasminogen activator and its receptor: cloning and induction by retinoic acid. Gene. 125:1993;177-183.
49. Fisher R., Waller E. K., Grossi G., Thompson D., Tizard R., Schleuning W. D. Isolation and characterization of the human tissue-type plasminogen activator structural gene including its 5′ flanking region. J. Biol. Chem. 260:1985;11223-11230.
50. Pepper M. S., Belin D., Montesano R., Orci L., Vassalli J.-D. Transforming growth factor beta-1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J. Cell Biol. 111:1990;743-755.
51. Pepper M. S., Soriano J. V., Menoud P. A., Sappino A. P., Orci L., Montesano R. Modulation of hepatocyte growth factor and c-met expression in the rat mammary gland during pregnancy, lactation and involution. Exp. Cell Res. 219:1995;204-210.
52. Millauer B., Wizigmann-Voos S., Schnürch H., Martinez R., Moller N. P. H., Risau W., Ullrich A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell. 72:1993;835-846.
53. Terman B. I., Dougher-Vermazen M., Carrion M. E., Dimitrov D., Armellino D. C., Gospodarowicz D., Böhlen P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun. 187:1992;1579-1586.
54. Waltenberger J., Claesson-Welsh L., Siegbahn A., Shibuya M., Heldin C. H. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem. 269:1994;26988-26995.
55. Carpentier J.-L., White M. F., Orci L., Kahn R. C. Direct visualizaion of the phosphorylated epidermal growth factor receptor during its internalization in A-431 cells. J. Cell Biol. 105:1987;2751-2762.
56. Pepper M. S., Montesano R., Mandriota S., Orci L., Vassalli J.-D. Angiogenesis: A paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enzyme Protein. 49:1996;138-162.
57. Pepper M. S., Ferrara N., Orci L., Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem. Biophys. Res. Commun. 181:1991;902-906.
58. Pepper M. S., Wasi S., Ferrara N., Orci L., Montesano R. In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells. Exp. Cell Res. 210:1994;298-305.
59. Mandriota S. J., Seghezzi G., Vassalli J. D., Ferrara N., Wasi S., Mazzieri R., Mignatti P., Pepper M. S. Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J. Biol. Chem. 270:1995;9709-9716.
60. Kandel J., Bossy-Wetzel E., Radvanyl F., Klagsbrun M., Folkman J., Hanahan D. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell. 66:1991;1095-1104.
61. Czubayko F., Liaudet-Coopman E. D. E., Aigner A., Tuveson A. T., Berchem G. J., Wellstein A. A secreted FGF-binding protein can serve as the angiogenic switch in human cancer. Nature Med. 3:1997;1137-1140.
62. Hewett P. W., Murray J. C. Coexpression offlt-1, flt-4KDR. Biochem. Biophys. Res. Commun. 221:1996;697-702.
63. Mandriota S. J., Pepper M. S. Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor. J Cell Sci. 110:1997;2293-2302.
64. Pepper, M. S. Mandriota, S. J. Jeltsch, M. Kumar, V. Alitalo, K. Vascular endothelial growth factor (VEGF)-C synergises with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro, and alters endothelial cell proteolytic properties.
65. Flaumenhaft R., Rifkin D. B. The extracellular regulation of growth factor action. Mol. Biol. Cell. 3:1992;1057-1065.
66. Sage E. H. Pieces of eight: Bioactive fragments of extracellular proteins as regulators of angiogenesis. Trends Cell Biol. 7:1997;182-186.
67. Nathan C., Sporn M. Cytokines in context. J. Cell Biol. 113:1991;981-986.